Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.76302 | 74 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.78468 | 73 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.76708 | 73 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.69727 | 72 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.71328 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.77378 | 74 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.1911 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.74208 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.73251 | 73 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.74517 | 73 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.80366 | 74 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.79226 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.7226 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.9703 | 75 |